Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4004742 | American Journal of Ophthalmology | 2007 | 10 Pages |
Abstract
Central toxic keratopathy is characterized by noninflammatory central corneal opacification with a significant hyperopic shift. The opacification gradually clears over a period of months, leaving the eye hyperopic. Enhancement is indicated to treat residual hyperopia and remove residual striae. Topical or oral corticosteroid treatment is not indicated. The cause of central toxic keratopathy is unknown.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Baris MD, Robert K. MD, MA (Oxon),